2026 Iowa House File 978
House File 978 (As Amended and Passed by the House April 21, 2025)
On page 3, lines 19-26, and lines 27-35
Sec. 2. NEW SECTION. 124F.1 Definitions.
23. “Qualified medical psilocybin provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to chapter 148, a physician assistant licensed pursuant to chapter 148C, an advanced registered nurse practitioner licensed under chapter 152, or an advanced practice registered nurse under chapter 152E, who is registered by the department under section 124F.22 to recommend treatment with psilocybin.
24. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to chapter 148, a physician assistant licensed pursuant to chapter 148C, an advanced registered nurse practitioner licensed under chapter 152, an advanced practice registered nurse under chapter 152E, a psychologist licensed pursuant to chapter 154B, or a social worker licensed pursuant to chapter 154C who is registered by the department to administer treatment with psilocybin.
On page 5, lines 12-21
Sec. 4. NEW SECTION. 124F.3 Notice to prospective and current public employees.
Prior to giving a current employee an assignment or duty that arises from or directly relates to an obligation under this chapter, or hiring a prospective employee whose assignments or duties would include an assignment or duty that arises from or directly relates to an obligation under this chapter, a state employer or a political subdivision employer shall give the employee or prospective employee a written notice that the employee’s or prospective employee’s job duties may require the employee or prospective employee to engage in conduct which is in violation of the criminal laws of the United States.
On page 8, at lines 27-30
Sec. 6. NEW SECTION. 124F.5 Psilocybin production establishment — license.
6. A psilocybin production establishment may be located at the same location as a medical cannabidiol manufacturer licensed pursuant to section 124E.6 if a separate license is obtained for each.
On page 9, at lines 16-19
Sec. 6. NEW SECTION. 124F.5 Psilocybin production establishment — license.
10. The licensing board may, at the discretion of the licensing board, grant preference to an applicant who currently holds a medical cannabidiol manufacturer license issued pursuant to section 124E.6.
Sec. 7. NEW SECTION. 124F.6 Psilocybin production establishment owners and directors — criminal background checks.
1. The division of criminal investigation of the department of public safety shall conduct a thorough investigation of each applicant for a psilocybin production establishment license as in a substantially similar manner as provided in section 124E.19. The division shall report the results of the investigation to the department.
On page 12, lines 23-32
Sec. 10. NEW SECTION. 124F.9 Psilocybin production establishment agent — registration.
2. None of the following individuals shall serve as a psilocybin production establishment agent or have the power to direct or cause the management or control of a psilocybin production establishment:
a. An advanced registered nurse practitioner licensed under chapter 152 or an advanced practice registered nurse under chapter 152E.
b. An individual licensed under chapter 148 to practice medicine and surgery or osteopathic medicine and surgery.
c. A physician assistant licensed under chapter 148C.
On page 18, lines 23-27
Sec. 16. NEW SECTION. 124F.15 Psilocybin production establishment — local control.
4. A local government shall not do any of the following:
a. Revoke from, or refuse to issue a license or permit to, a psilocybin production establishment on the sole basis that the applicant or psilocybin production establishment violates federal law regarding the legal status of psilocybin.
On page 26, lines 28-33
Sec. 24. NEW SECTION. 124F.23 Standard of care — provider not liable — no private right of action.
1. A qualified medical psilocybin provider or a qualified therapy provider who recommends or administers psilocybin in compliance with this chapter shall not be subject to a civil or criminal penalty, or license discipline, solely for violating a federal law or regulation that prohibits recommending, prescribing, possessing, or dispensing psilocybin or a psilocybin product.
On page 27, lines 13-20
Sec. 25. NEW SECTION. 124F.24 Nondiscrimination for medical care or government employment.
This paragraph shall not apply in any of the following circumstances:
(1) The employee’s use of psilocybin jeopardizes federal funding, a federal security clearance, or any other federal background determination required for the employee’s position.
(2) The employee’s position is dependent on a license or peace officer certification that is subject to federal regulations, including 18 U.S.C. § 922(g)(3).
Sec. 33. NEW SECTION. 124F.32 Contracts enforceable.
It is the public policy of this state that contracts related to the production, sale, and administration of psilocybin pursuant to this chapter shall be enforceable. It is the public policy of this state that no contract entered into by a psilocybin production establishment, qualified medical psilocybin provider, or qualified therapy provider, or its employees or agents as permitted pursuant to a valid registration, or by an entity who allows property to be used by an establishment, qualified medical psilocybin provider, or qualified therapy provider, its employees, or its agents as permitted pursuant to a valid registration, shall be unenforceable on the basis that cultivating, obtaining, manufacturing, distributing, dispensing, transporting, selling, possessing, or using psilocybin is prohibited by federal law.